Viereck V - Search Results

1

Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trial.

Viereck V, Gamper M, Regauer S, Walser C, Zivanovic I. Viereck V, et al. Arch Gynecol Obstet. 2023 Aug;308(2):643-649. doi: 10.1007/s00404-023-07055-z. Epub 2023 May 5. Arch Gynecol Obstet. 2023. PMID: 37145134 Free PMC article.

2

Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis.

Gamper M, Viereck V, Geissbühler V, Eberhard J, Binder J, Moll C, Rehrauer H, Moser R. Gamper M, et al. Among authors: viereck v. BMC Genomics. 2009 Apr 28;10:199. doi: 10.1186/1471-2164-10-199. BMC Genomics. 2009. PMID: 19400928 Free PMC article.

3

Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.

Gamper M, Viereck V, Eberhard J, Binder J, Moll C, Welter J, Moser R. Gamper M, et al. Among authors: viereck v. Int Urogynecol J. 2013 Dec;24(12):2049-57. doi: 10.1007/s00192-013-2112-0. Epub 2013 May 14. Int Urogynecol J. 2013. PMID: 23670165 Free PMC article.

4

Bladder perforation after TVT-Secur procedure: how secure is TVT-Secur?

Zivanovic I, Kociszewski J, Eberhard J, Viereck V. Zivanovic I, et al. Among authors: viereck v. Arch Gynecol Obstet. 2014 Jan;289(1):131-4. doi: 10.1007/s00404-013-2968-8. Epub 2013 Jul 19. Arch Gynecol Obstet. 2014. PMID: 23867901

5

Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?

Gamper M, Regauer S, Welter J, Eberhard J, Viereck V. Gamper M, et al. Among authors: viereck v. J Urol. 2015 Jun;193(6):1994-2000. doi: 10.1016/j.juro.2015.01.036. Epub 2015 Jan 14. J Urol. 2015. PMID: 25596361

6

Have we been led astray by the NGF biomarker data?

Gamper M, Moser R, Viereck V. Gamper M, et al. Among authors: viereck v. Neurourol Urodyn. 2017 Jan;36(1):203-204. doi: 10.1002/nau.22882. Epub 2015 Sep 18. Neurourol Urodyn. 2017. PMID: 26384156 Free article. No abstract available.

7

Urethral bulking for recurrent stress urinary incontinence after midurethral sling failure.

Zivanovic I, Rautenberg O, Lobodasch K, von Bünau G, Walser C, Viereck V. Zivanovic I, et al. Among authors: viereck v. Neurourol Urodyn. 2017 Mar;36(3):722-726. doi: 10.1002/nau.23007. Epub 2016 Mar 31. Neurourol Urodyn. 2017. PMID: 27037856 Free article.

8

Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.

Regauer S, Gamper M, Fehr MK, Viereck V. Regauer S, et al. Among authors: viereck v. J Urol. 2017 Jan;197(1):159-166. doi: 10.1016/j.juro.2016.06.089. Epub 2016 Jul 1. J Urol. 2017. PMID: 27378135

9

Role of intrinsic sphincter deficiency with and without urethral hypomobility on the outcome of tape insertion.

Wlaźlak E, Viereck V, Kociszewski J, Kuszka A, Rautenberg O, Walser C, Surkont G, Gamper M, Fehr MK. Wlaźlak E, et al. Among authors: viereck v. Neurourol Urodyn. 2017 Sep;36(7):1910-1916. doi: 10.1002/nau.23211. Epub 2017 Jan 31. Neurourol Urodyn. 2017. PMID: 28139863

10

Re: Sheng W, Zhang H, Kirschner-Hermanns R. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Neurourol Urodyn. 2017;9999:1-8. doi: 10.1002/nau.23210.

Gamper M, Viereck V. Gamper M, et al. Among authors: viereck v. Neurourol Urodyn. 2017 Nov;36(8):2190-2191. doi: 10.1002/nau.23268. Epub 2017 Mar 27. Neurourol Urodyn. 2017. PMID: 28346713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters